Plasma levels of trefoil factors are increased in patients with advanced prostate cancer

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Plasma levels of trefoil factors are increased in patients with advanced prostate cancer. / Vestergaard, E.M.; Borregaard, Michael Krabbe; Poulsen, Steen Seier; Nexo, E.; Torring, N.

In: Clinical Cancer Research, Vol. 12, No. 3 Pt 1, 2006, p. 807-812.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Vestergaard, EM, Borregaard, MK, Poulsen, SS, Nexo, E & Torring, N 2006, 'Plasma levels of trefoil factors are increased in patients with advanced prostate cancer', Clinical Cancer Research, vol. 12, no. 3 Pt 1, pp. 807-812. https://doi.org/10.1158/1078-0432.CCR-05-1545

APA

Vestergaard, E. M., Borregaard, M. K., Poulsen, S. S., Nexo, E., & Torring, N. (2006). Plasma levels of trefoil factors are increased in patients with advanced prostate cancer. Clinical Cancer Research, 12(3 Pt 1), 807-812. https://doi.org/10.1158/1078-0432.CCR-05-1545

Vancouver

Vestergaard EM, Borregaard MK, Poulsen SS, Nexo E, Torring N. Plasma levels of trefoil factors are increased in patients with advanced prostate cancer. Clinical Cancer Research. 2006;12(3 Pt 1):807-812. https://doi.org/10.1158/1078-0432.CCR-05-1545

Author

Vestergaard, E.M. ; Borregaard, Michael Krabbe ; Poulsen, Steen Seier ; Nexo, E. ; Torring, N. / Plasma levels of trefoil factors are increased in patients with advanced prostate cancer. In: Clinical Cancer Research. 2006 ; Vol. 12, No. 3 Pt 1. pp. 807-812.

Bibtex

@article{2c81d05070ec11dcbee902004c4f4f50,
title = "Plasma levels of trefoil factors are increased in patients with advanced prostate cancer",
abstract = "Through cDNA array analyses and immunohistochemistry on tissue microarrays, trefoil factor 3 (TFF3) was recently shown to be overexpressed in prostate cancer. The purpose of this study was to test the feasibility of using the levels of trefoil factors as a plasma marker for prostate cancer.",
keywords = "Aged, Aged, 80 and over, Enzyme-Linked Immunosorbent Assay, Gene Expression Regulation, Neoplastic, Humans, Immunohistochemistry, Male, Middle Aged, Peptides, Prospective Studies, Prostate-Specific Antigen, Prostatic Neoplasms, Sensitivity and Specificity, Tumor Suppressor Proteins",
author = "E.M. Vestergaard and Borregaard, {Michael Krabbe} and Poulsen, {Steen Seier} and E. Nexo and N. Torring",
year = "2006",
doi = "10.1158/1078-0432.CCR-05-1545",
language = "English",
volume = "12",
pages = "807--812",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research (A A C R)",
number = "3 Pt 1",

}

RIS

TY - JOUR

T1 - Plasma levels of trefoil factors are increased in patients with advanced prostate cancer

AU - Vestergaard, E.M.

AU - Borregaard, Michael Krabbe

AU - Poulsen, Steen Seier

AU - Nexo, E.

AU - Torring, N.

PY - 2006

Y1 - 2006

N2 - Through cDNA array analyses and immunohistochemistry on tissue microarrays, trefoil factor 3 (TFF3) was recently shown to be overexpressed in prostate cancer. The purpose of this study was to test the feasibility of using the levels of trefoil factors as a plasma marker for prostate cancer.

AB - Through cDNA array analyses and immunohistochemistry on tissue microarrays, trefoil factor 3 (TFF3) was recently shown to be overexpressed in prostate cancer. The purpose of this study was to test the feasibility of using the levels of trefoil factors as a plasma marker for prostate cancer.

KW - Aged

KW - Aged, 80 and over

KW - Enzyme-Linked Immunosorbent Assay

KW - Gene Expression Regulation, Neoplastic

KW - Humans

KW - Immunohistochemistry

KW - Male

KW - Middle Aged

KW - Peptides

KW - Prospective Studies

KW - Prostate-Specific Antigen

KW - Prostatic Neoplasms

KW - Sensitivity and Specificity

KW - Tumor Suppressor Proteins

U2 - 10.1158/1078-0432.CCR-05-1545

DO - 10.1158/1078-0432.CCR-05-1545

M3 - Journal article

C2 - 16467092

VL - 12

SP - 807

EP - 812

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 3 Pt 1

ER -

ID: 1207944